

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.66644366 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.66644366 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.93847461 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.85419423 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.41922994 |
| 6 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.81622604 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 4.80019039 |
| 8 | positive thymic T cell selection (GO:0045059) | 4.79869695 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.55659362 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.55659362 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 4.51568429 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.49790978 |
| 13 | negative thymic T cell selection (GO:0045060) | 4.30809478 |
| 14 | negative T cell selection (GO:0043383) | 4.27953158 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.02036020 |
| 16 | DNA deamination (GO:0045006) | 3.97301327 |
| 17 | thymic T cell selection (GO:0045061) | 3.95752990 |
| 18 | viral transcription (GO:0019083) | 3.94355835 |
| 19 | DNA unwinding involved in DNA replication (GO:0006268) | 3.69968287 |
| 20 | translational termination (GO:0006415) | 3.68966237 |
| 21 | positive T cell selection (GO:0043368) | 3.61548094 |
| 22 | response to interleukin-15 (GO:0070672) | 3.60423268 |
| 23 | positive regulation of lamellipodium assembly (GO:0010592) | 3.60154929 |
| 24 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.53951749 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.51485597 |
| 26 | translational elongation (GO:0006414) | 3.48954440 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48536229 |
| 28 | detection of bacterium (GO:0016045) | 3.46959244 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.44918065 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.44918065 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.44918065 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.44918065 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.44918065 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.44918065 |
| 35 | positive regulation of B cell differentiation (GO:0045579) | 3.42893684 |
| 36 | regulation of B cell differentiation (GO:0045577) | 3.41782882 |
| 37 | T cell selection (GO:0045058) | 3.40697631 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.39866086 |
| 39 | T cell migration (GO:0072678) | 3.37875647 |
| 40 | detection of other organism (GO:0098543) | 3.34933252 |
| 41 | response to peptidoglycan (GO:0032494) | 3.32433342 |
| 42 | natural killer cell differentiation (GO:0001779) | 3.24337655 |
| 43 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.23159761 |
| 44 | negative regulation of phagocytosis (GO:0050765) | 3.22726857 |
| 45 | leukocyte aggregation (GO:0070486) | 3.20664079 |
| 46 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.19856288 |
| 47 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.18434040 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.16466800 |
| 49 | mannose metabolic process (GO:0006013) | 3.14914775 |
| 50 | positive regulation of lamellipodium organization (GO:1902745) | 3.11037332 |
| 51 | positive regulation of histone deacetylation (GO:0031065) | 3.06809313 |
| 52 | COPI coating of Golgi vesicle (GO:0048205) | 3.03637773 |
| 53 | Golgi transport vesicle coating (GO:0048200) | 3.03637773 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 3.02215886 |
| 55 | DNA strand elongation (GO:0022616) | 3.01892451 |
| 56 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.01376712 |
| 57 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.00039060 |
| 58 | cellular response to interleukin-4 (GO:0071353) | 2.97530854 |
| 59 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.97318699 |
| 60 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.96890144 |
| 61 | regulation of extracellular matrix disassembly (GO:0010715) | 2.96479164 |
| 62 | positive regulation of isotype switching (GO:0045830) | 2.95605842 |
| 63 | pinocytosis (GO:0006907) | 2.95124310 |
| 64 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94363596 |
| 65 | response to muramyl dipeptide (GO:0032495) | 2.93784270 |
| 66 | regulation of response to interferon-gamma (GO:0060330) | 2.92213362 |
| 67 | negative regulation of RNA splicing (GO:0033119) | 2.92133281 |
| 68 | maturation of SSU-rRNA (GO:0030490) | 2.90869492 |
| 69 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.90159249 |
| 70 | pentose-phosphate shunt (GO:0006098) | 2.89998390 |
| 71 | translational initiation (GO:0006413) | 2.89541330 |
| 72 | cellular response to interleukin-15 (GO:0071350) | 2.89507898 |
| 73 | viral life cycle (GO:0019058) | 2.88613123 |
| 74 | T cell apoptotic process (GO:0070231) | 2.88198583 |
| 75 | protein targeting to ER (GO:0045047) | 2.88036070 |
| 76 | detection of external biotic stimulus (GO:0098581) | 2.87735050 |
| 77 | protein localization to endosome (GO:0036010) | 2.85541217 |
| 78 | cellular response to virus (GO:0098586) | 2.84450774 |
| 79 | cotranslational protein targeting to membrane (GO:0006613) | 2.84071494 |
| 80 | Peyers patch development (GO:0048541) | 2.82322747 |
| 81 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.82322747 |
| 82 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.81587738 |
| 83 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.78855959 |
| 84 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.77223478 |
| 85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77174335 |
| 86 | neutrophil activation involved in immune response (GO:0002283) | 2.76656043 |
| 87 | cellular protein complex disassembly (GO:0043624) | 2.76469562 |
| 88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75352243 |
| 89 | positive regulation of extracellular matrix organization (GO:1903055) | 2.73777204 |
| 90 | negative regulation of viral release from host cell (GO:1902187) | 2.73544929 |
| 91 | * T cell receptor signaling pathway (GO:0050852) | 2.73482641 |
| 92 | positive regulation of protein deacetylation (GO:0090312) | 2.72186805 |
| 93 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.72134218 |
| 94 | regulation of superoxide anion generation (GO:0032928) | 2.71396524 |
| 95 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.70664773 |
| 96 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.70404792 |
| 97 | T cell costimulation (GO:0031295) | 2.69633062 |
| 98 | dosage compensation (GO:0007549) | 2.69068837 |
| 99 | NIK/NF-kappaB signaling (GO:0038061) | 2.68978020 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68560428 |
| 101 | T cell homeostasis (GO:0043029) | 2.68414391 |
| 102 | protein complex disassembly (GO:0043241) | 2.67523018 |
| 103 | response to type I interferon (GO:0034340) | 2.66971752 |
| 104 | protein localization to endoplasmic reticulum (GO:0070972) | 2.66328060 |
| 105 | lymphocyte costimulation (GO:0031294) | 2.66017631 |
| 106 | response to interleukin-4 (GO:0070670) | 2.65334526 |
| 107 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.64871272 |
| 108 | modulation by symbiont of host cellular process (GO:0044068) | 2.64420486 |
| 109 | cellular response to type I interferon (GO:0071357) | 2.63312562 |
| 110 | type I interferon signaling pathway (GO:0060337) | 2.63312562 |
| 111 | formation of translation preinitiation complex (GO:0001731) | 2.62037465 |
| 112 | barbed-end actin filament capping (GO:0051016) | 2.58509163 |
| 113 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57229361 |
| 114 | ribosomal small subunit biogenesis (GO:0042274) | 2.56446659 |
| 115 | B cell mediated immunity (GO:0019724) | 2.56403706 |
| 116 | ncRNA 3-end processing (GO:0043628) | 2.56217852 |
| 117 | germinal center formation (GO:0002467) | 2.54797132 |
| 118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.54307186 |
| 119 | cellular response to zinc ion (GO:0071294) | 2.53975030 |
| 120 | IMP biosynthetic process (GO:0006188) | 2.53799559 |
| 121 | regulation of translational fidelity (GO:0006450) | 2.53671793 |
| 122 | detection of biotic stimulus (GO:0009595) | 2.53417352 |
| 123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52891685 |
| 124 | regulation of extracellular matrix organization (GO:1903053) | 2.52126797 |
| 125 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.50809349 |
| 126 | immunoglobulin mediated immune response (GO:0016064) | 2.50753785 |
| 127 | glucose 6-phosphate metabolic process (GO:0051156) | 2.50093596 |
| 128 | lymphocyte apoptotic process (GO:0070227) | 2.49846972 |
| 129 | response to host (GO:0075136) | 2.49575297 |
| 130 | response to host defenses (GO:0052200) | 2.49575297 |
| 131 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.49575297 |
| 132 | leukocyte cell-cell adhesion (GO:0007159) | 2.49076778 |
| 133 | protein retention in ER lumen (GO:0006621) | 2.48661380 |
| 134 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.47404405 |
| 135 | macromolecular complex disassembly (GO:0032984) | 2.47061722 |
| 136 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.46651859 |
| 137 | mast cell activation (GO:0045576) | 2.46356534 |
| 138 | regulation of protein heterodimerization activity (GO:0043497) | 2.45686632 |
| 139 | DNA replication initiation (GO:0006270) | 2.45546940 |
| 140 | response to laminar fluid shear stress (GO:0034616) | 2.44613031 |
| 141 | modulation by virus of host process (GO:0019054) | 2.44540237 |
| 142 | detection of molecule of bacterial origin (GO:0032490) | 2.44155447 |
| 143 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43881137 |
| 144 | myeloid dendritic cell differentiation (GO:0043011) | 2.41708646 |
| 145 | regulation of cholesterol homeostasis (GO:2000188) | 2.40595470 |
| 146 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.40587211 |
| 147 | negative regulation of fibrinolysis (GO:0051918) | 2.39593158 |
| 148 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.39187857 |
| 149 | negative regulation of innate immune response (GO:0045824) | 2.37622737 |
| 150 | protein carboxylation (GO:0018214) | 2.35026185 |
| 151 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.35026185 |
| 152 | regulation of plasminogen activation (GO:0010755) | 2.32814923 |
| 153 | regulation of leukocyte degranulation (GO:0043300) | 2.32341646 |
| 154 | response to host immune response (GO:0052572) | 2.31409628 |
| 155 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.31409628 |
| 156 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.30023323 |
| 157 | regulation of viral release from host cell (GO:1902186) | 2.28989374 |
| 158 | apoptotic process involved in morphogenesis (GO:0060561) | 2.27195212 |
| 159 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.26875455 |
| 160 | signal complex assembly (GO:0007172) | 2.25457936 |
| 161 | activation of Rac GTPase activity (GO:0032863) | 2.25383088 |
| 162 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.25010959 |
| 163 | regulation of mast cell degranulation (GO:0043304) | 2.24759691 |
| 164 | positive regulation of type 2 immune response (GO:0002830) | 2.24046110 |
| 165 | GDP-mannose metabolic process (GO:0019673) | 2.23127308 |
| 166 | response to interferon-alpha (GO:0035455) | 2.23018510 |
| 167 | positive regulation of interferon-alpha production (GO:0032727) | 2.22617625 |
| 168 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.21817654 |
| 169 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.21742140 |
| 170 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.21742140 |
| 171 | negative regulation of digestive system process (GO:0060457) | 2.21162279 |
| 172 | stress fiber assembly (GO:0043149) | 2.21107359 |
| 173 | negative regulation of interleukin-12 production (GO:0032695) | 2.19762664 |
| 174 | protein-lipid complex assembly (GO:0065005) | 2.19754182 |
| 175 | desmosome organization (GO:0002934) | 2.18701129 |
| 176 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.18064128 |
| 177 | negative regulation of cell size (GO:0045792) | 2.17195697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.27869813 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.69944352 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.69456226 |
| 4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.41600285 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.84805517 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56175631 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50291490 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.38707621 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34789700 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.28099639 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.23869088 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21992352 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.15559069 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11102857 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10900553 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04280075 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.02091558 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98869691 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98362995 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.97692312 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.97035845 |
| 22 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.95703854 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95196493 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91958058 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.86694381 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81031767 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 1.77972438 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77243922 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76361067 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74100373 |
| 31 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70955069 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68453464 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68130813 |
| 34 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67987121 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.66947801 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.65937117 |
| 37 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.65802799 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63239419 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63122343 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.61938307 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61462686 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60115772 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60066171 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59661316 |
| 45 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.59615813 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59580856 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59484642 |
| 48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.59242701 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58727371 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57011911 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55547441 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.54093119 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52908751 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50837467 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50226462 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48274997 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45685030 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44950649 |
| 59 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.44242695 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42835285 |
| 61 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42693204 |
| 62 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42255688 |
| 63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41657829 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41349057 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40665024 |
| 66 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40092650 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40022478 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39409288 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38311723 |
| 70 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37873279 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36667201 |
| 72 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.35208691 |
| 73 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.32462559 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30259440 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29322745 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28133964 |
| 77 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26806139 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25861569 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.24144518 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23709572 |
| 81 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.23170830 |
| 82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23126301 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23047029 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22987803 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22773496 |
| 86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21831615 |
| 87 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21584240 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20604284 |
| 89 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20445595 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20044151 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19470761 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18084607 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17978215 |
| 94 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17706238 |
| 95 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17316331 |
| 96 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.16482875 |
| 97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16479924 |
| 98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16186765 |
| 99 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15358629 |
| 100 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15287780 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14299725 |
| 102 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14260073 |
| 103 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14227444 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13031035 |
| 105 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.11880482 |
| 106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.10854554 |
| 107 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.10308034 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10209320 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09914462 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09718401 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09292792 |
| 112 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09005495 |
| 113 | P68_20966046_ChIP-Seq_HELA_Human | 1.08641487 |
| 114 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.08509206 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08138695 |
| 116 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08110798 |
| 117 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.07869890 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07022085 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06938911 |
| 120 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06848264 |
| 121 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06718290 |
| 122 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06449481 |
| 123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06343348 |
| 124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05701650 |
| 125 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05323011 |
| 126 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05218286 |
| 127 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04688085 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04604328 |
| 129 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03355803 |
| 130 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02757764 |
| 131 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02512619 |
| 132 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02196812 |
| 133 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.01860853 |
| 134 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01785017 |
| 135 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01260800 |
| 136 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99543291 |
| 137 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98723429 |
| 138 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.96655848 |
| 139 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.96562297 |
| 140 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95256843 |
| 141 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94014493 |
| 142 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93668335 |
| 143 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92778108 |
| 144 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92586317 |
| 145 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92171210 |
| 146 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92011762 |
| 147 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91864814 |
| 148 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91731596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.52032129 |
| 2 | MP0000685_abnormal_immune_system | 3.47757150 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.44950600 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.12990173 |
| 5 | MP0005451_abnormal_body_composition | 2.82071267 |
| 6 | MP0005671_abnormal_response_to | 2.79537400 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.79144371 |
| 8 | MP0001800_abnormal_humoral_immune | 2.64406511 |
| 9 | MP0002398_abnormal_bone_marrow | 2.53332955 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.42605449 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.34060538 |
| 12 | MP0009785_altered_susceptibility_to | 2.31322484 |
| 13 | MP0005387_immune_system_phenotype | 2.28703551 |
| 14 | MP0001790_abnormal_immune_system | 2.28703551 |
| 15 | MP0001873_stomach_inflammation | 2.24056239 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.23733006 |
| 17 | MP0001819_abnormal_immune_cell | 2.20252343 |
| 18 | MP0002723_abnormal_immune_serum | 2.18651801 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.17142780 |
| 20 | MP0002722_abnormal_immune_system | 2.16885158 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.15602167 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.14764160 |
| 23 | MP0000689_abnormal_spleen_morphology | 2.12529524 |
| 24 | MP0003436_decreased_susceptibility_to | 2.12113651 |
| 25 | MP0005025_abnormal_response_to | 2.11690240 |
| 26 | MP0000716_abnormal_immune_system | 2.10273493 |
| 27 | MP0008260_abnormal_autophagy | 2.08959245 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 2.08008982 |
| 29 | MP0001545_abnormal_hematopoietic_system | 2.08008982 |
| 30 | MP0000703_abnormal_thymus_morphology | 2.07545787 |
| 31 | MP0005464_abnormal_platelet_physiology | 2.05853301 |
| 32 | MP0003866_abnormal_defecation | 2.05823150 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.99919255 |
| 34 | MP0002405_respiratory_system_inflammati | 1.96830262 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.95508325 |
| 36 | MP0003693_abnormal_embryo_hatching | 1.95283311 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.93228924 |
| 38 | MP0002429_abnormal_blood_cell | 1.91649190 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.88596011 |
| 40 | MP0004947_skin_inflammation | 1.86424645 |
| 41 | MP0002006_tumorigenesis | 1.79041513 |
| 42 | MP0000490_abnormal_crypts_of | 1.74594694 |
| 43 | MP0003303_peritoneal_inflammation | 1.71605104 |
| 44 | MP0001853_heart_inflammation | 1.69293411 |
| 45 | MP0003111_abnormal_nucleus_morphology | 1.66627574 |
| 46 | MP0009278_abnormal_bone_marrow | 1.64952506 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.59519132 |
| 48 | MP0004858_abnormal_nervous_system | 1.52955782 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.51850072 |
| 50 | MP0002419_abnormal_innate_immunity | 1.50795320 |
| 51 | MP0003077_abnormal_cell_cycle | 1.49666869 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.45889291 |
| 53 | MP0004957_abnormal_blastocyst_morpholog | 1.44449654 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.41136980 |
| 55 | MP0006082_CNS_inflammation | 1.40773992 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.40456025 |
| 57 | MP0003075_altered_response_to | 1.36900165 |
| 58 | MP0008961_abnormal_basal_metabolism | 1.35942416 |
| 59 | MP0009840_abnormal_foam_cell | 1.33960036 |
| 60 | MP0000678_abnormal_parathyroid_gland | 1.33894669 |
| 61 | MP0003724_increased_susceptibility_to | 1.31465304 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.30511417 |
| 63 | MP0000858_altered_metastatic_potential | 1.27920192 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 1.26891450 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.25232747 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.23909958 |
| 67 | MP0004510_myositis | 1.23225203 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.21881879 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.21181960 |
| 70 | MP0003091_abnormal_cell_migration | 1.18944588 |
| 71 | MP0002933_joint_inflammation | 1.18814108 |
| 72 | MP0008469_abnormal_protein_level | 1.15570110 |
| 73 | MP0005409_darkened_coat_color | 1.15315776 |
| 74 | MP0003329_amyloid_beta_deposits | 1.12550697 |
| 75 | MP0005365_abnormal_bile_salt | 1.12453928 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.12263370 |
| 77 | MP0004381_abnormal_hair_follicle | 1.10480491 |
| 78 | MP0005666_abnormal_adipose_tissue | 1.10208279 |
| 79 | MP0006054_spinal_hemorrhage | 1.10103985 |
| 80 | MP0005083_abnormal_biliary_tract | 1.08816752 |
| 81 | MP0000604_amyloidosis | 1.08061355 |
| 82 | MP0005164_abnormal_response_to | 1.07502749 |
| 83 | MP0005310_abnormal_salivary_gland | 1.07161195 |
| 84 | MP0010307_abnormal_tumor_latency | 1.05928994 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 1.04797561 |
| 86 | MP0005174_abnormal_tail_pigmentation | 1.04761197 |
| 87 | MP0001958_emphysema | 1.03297423 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.03040264 |
| 89 | MP0005023_abnormal_wound_healing | 1.01864922 |
| 90 | MP0001730_embryonic_growth_arrest | 1.01425237 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 1.00919970 |
| 92 | MP0008057_abnormal_DNA_replication | 1.00622832 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 0.98630902 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.98509856 |
| 95 | MP0008004_abnormal_stomach_pH | 0.98333303 |
| 96 | MP0005670_abnormal_white_adipose | 0.96126958 |
| 97 | MP0003279_aneurysm | 0.96083915 |
| 98 | MP0001851_eye_inflammation | 0.95579021 |
| 99 | MP0000609_abnormal_liver_physiology | 0.95166759 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 0.94435992 |
| 101 | MP0005390_skeleton_phenotype | 0.94309469 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.92944872 |
| 103 | MP0000313_abnormal_cell_death | 0.92334190 |
| 104 | MP0002060_abnormal_skin_morphology | 0.90481178 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.90432243 |
| 106 | MP0000477_abnormal_intestine_morphology | 0.89948485 |
| 107 | MP0001348_abnormal_lacrimal_gland | 0.89844998 |
| 108 | MP0005375_adipose_tissue_phenotype | 0.89163440 |
| 109 | MP0008007_abnormal_cellular_replicative | 0.89077531 |
| 110 | MP0005165_increased_susceptibility_to | 0.89037294 |
| 111 | MP0002796_impaired_skin_barrier | 0.87932506 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.87351438 |
| 113 | MP0000350_abnormal_cell_proliferation | 0.87125721 |
| 114 | MP0001533_abnormal_skeleton_physiology | 0.87040032 |
| 115 | MP0009764_decreased_sensitivity_to | 0.86750597 |
| 116 | MP0004883_abnormal_blood_vessel | 0.83074282 |
| 117 | MP0000343_altered_response_to | 0.82892155 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.82569491 |
| 119 | MP0002132_abnormal_respiratory_system | 0.81357636 |
| 120 | MP0000598_abnormal_liver_morphology | 0.80977440 |
| 121 | MP0008058_abnormal_DNA_repair | 0.78818340 |
| 122 | MP0000371_diluted_coat_color | 0.77973356 |
| 123 | MP0002089_abnormal_postnatal_growth/wei | 0.75714481 |
| 124 | MP0009763_increased_sensitivity_to | 0.75297784 |
| 125 | MP0003448_altered_tumor_morphology | 0.75251425 |
| 126 | MP0002080_prenatal_lethality | 0.72947065 |
| 127 | MP0009643_abnormal_urine_homeostasis | 0.65966453 |
| 128 | MP0005166_decreased_susceptibility_to | 0.65558633 |
| 129 | MP0003453_abnormal_keratinocyte_physiol | 0.64163956 |
| 130 | MP0001663_abnormal_digestive_system | 0.63144808 |
| 131 | MP0002136_abnormal_kidney_physiology | 0.62571459 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.61746041 |
| 133 | MP0002086_abnormal_extraembryonic_tissu | 0.61243269 |
| 134 | MP0002970_abnormal_white_adipose | 0.61220167 |
| 135 | MP0005319_abnormal_enzyme/_coenzyme | 0.60441810 |
| 136 | MP0002095_abnormal_skin_pigmentation | 0.59911438 |
| 137 | MP0002877_abnormal_melanocyte_morpholog | 0.58551472 |
| 138 | MP0005360_urolithiasis | 0.58549341 |
| 139 | MP0001849_ear_inflammation | 0.58086483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 4.61823472 |
| 2 | IgM deficiency (HP:0002850) | 4.30890473 |
| 3 | Recurrent bronchitis (HP:0002837) | 4.06034437 |
| 4 | Nasal polyposis (HP:0100582) | 4.02131391 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.96533884 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.92314556 |
| 7 | T lymphocytopenia (HP:0005403) | 3.89098759 |
| 8 | Abnormality of the nasal mucosa (HP:0000433) | 3.84849392 |
| 9 | Abnormality of T cells (HP:0002843) | 3.80650011 |
| 10 | Abnormality of T cell number (HP:0011839) | 3.69392080 |
| 11 | Thrombocytosis (HP:0001894) | 3.52495272 |
| 12 | Abnormality of T cell physiology (HP:0011840) | 3.43995197 |
| 13 | Recurrent viral infections (HP:0004429) | 3.43966327 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.24772382 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.15172228 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.06837772 |
| 17 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.06513659 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 3.05443303 |
| 19 | Pustule (HP:0200039) | 3.04545013 |
| 20 | Hemorrhage of the eye (HP:0011885) | 3.03486517 |
| 21 | Combined immunodeficiency (HP:0005387) | 3.02448351 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 2.99810249 |
| 23 | Orchitis (HP:0100796) | 2.98977828 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 2.98042087 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.97141257 |
| 26 | Abnormal number of erythroid precursors (HP:0012131) | 2.92526519 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.91627774 |
| 28 | Cellulitis (HP:0100658) | 2.86038830 |
| 29 | Hyperacusis (HP:0010780) | 2.84770998 |
| 30 | Inflammation of the large intestine (HP:0002037) | 2.83296286 |
| 31 | Myositis (HP:0100614) | 2.83268149 |
| 32 | Basal cell carcinoma (HP:0002671) | 2.77999567 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.77379904 |
| 34 | Verrucae (HP:0200043) | 2.76496018 |
| 35 | Papilloma (HP:0012740) | 2.76496018 |
| 36 | Eczematoid dermatitis (HP:0000976) | 2.75896331 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 2.75545214 |
| 38 | Lymphopenia (HP:0001888) | 2.75516562 |
| 39 | Prolonged bleeding time (HP:0003010) | 2.68579092 |
| 40 | Increased IgE level (HP:0003212) | 2.67220074 |
| 41 | Abnormality of the fingertips (HP:0001211) | 2.60382928 |
| 42 | Petechiae (HP:0000967) | 2.58216208 |
| 43 | Vertebral compression fractures (HP:0002953) | 2.58055752 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.57916239 |
| 45 | IgG deficiency (HP:0004315) | 2.56825307 |
| 46 | Amyloidosis (HP:0011034) | 2.53824114 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.53668713 |
| 48 | Abnormality of B cell number (HP:0010975) | 2.53639129 |
| 49 | B lymphocytopenia (HP:0010976) | 2.53639129 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.52924575 |
| 51 | Purpura (HP:0000979) | 2.52773221 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52769339 |
| 53 | Joint hemorrhage (HP:0005261) | 2.47955474 |
| 54 | Reticulocytopenia (HP:0001896) | 2.47811605 |
| 55 | Broad face (HP:0000283) | 2.42467382 |
| 56 | Abnormality of complement system (HP:0005339) | 2.41876412 |
| 57 | Colitis (HP:0002583) | 2.41278004 |
| 58 | Thin bony cortex (HP:0002753) | 2.39285404 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.37839702 |
| 60 | IgA deficiency (HP:0002720) | 2.36889867 |
| 61 | Poikiloderma (HP:0001029) | 2.34255273 |
| 62 | Thyroiditis (HP:0100646) | 2.34059958 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.33630267 |
| 64 | Optic neuritis (HP:0100653) | 2.33630267 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.33623923 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33623923 |
| 67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33417534 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33417534 |
| 69 | Abnormal platelet function (HP:0011869) | 2.32693817 |
| 70 | Impaired platelet aggregation (HP:0003540) | 2.32693817 |
| 71 | Epistaxis (HP:0000421) | 2.32617089 |
| 72 | Peritonitis (HP:0002586) | 2.32407070 |
| 73 | Polygenic inheritance (HP:0010982) | 2.31075032 |
| 74 | Meningitis (HP:0001287) | 2.29684456 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29476793 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29476793 |
| 77 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29476793 |
| 78 | Recurrent abscess formation (HP:0002722) | 2.29175814 |
| 79 | Gingivitis (HP:0000230) | 2.28270044 |
| 80 | Cervical subluxation (HP:0003308) | 2.27955021 |
| 81 | Loss of speech (HP:0002371) | 2.25741274 |
| 82 | Bronchitis (HP:0012387) | 2.23639088 |
| 83 | Emphysema (HP:0002097) | 2.23331364 |
| 84 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18992240 |
| 85 | Obstructive lung disease (HP:0006536) | 2.18992240 |
| 86 | Lymphoma (HP:0002665) | 2.18356281 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 2.14713348 |
| 88 | Complement deficiency (HP:0004431) | 2.13545253 |
| 89 | Menorrhagia (HP:0000132) | 2.12156375 |
| 90 | Hypoplasia of the thymus (HP:0000778) | 2.10780863 |
| 91 | Flat acetabular roof (HP:0003180) | 2.05505813 |
| 92 | Axonal loss (HP:0003447) | 2.04329147 |
| 93 | Multiple enchondromatosis (HP:0005701) | 2.04113266 |
| 94 | Malnutrition (HP:0004395) | 2.04002710 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 2.02041456 |
| 96 | Atrophic scars (HP:0001075) | 2.01851374 |
| 97 | Aplastic anemia (HP:0001915) | 2.00408606 |
| 98 | Short nail (HP:0001799) | 2.00138992 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 1.98582186 |
| 100 | Increased density of long bones (HP:0006392) | 1.98109604 |
| 101 | Recurrent bacterial skin infections (HP:0005406) | 1.97940669 |
| 102 | Urticaria (HP:0001025) | 1.97560446 |
| 103 | Elfin facies (HP:0004428) | 1.97388605 |
| 104 | Stomatitis (HP:0010280) | 1.97173487 |
| 105 | Vasculitis (HP:0002633) | 1.97025170 |
| 106 | Distal lower limb amyotrophy (HP:0008944) | 1.96433485 |
| 107 | Abnormality of the thoracic spine (HP:0100711) | 1.96105541 |
| 108 | Neurofibrillary tangles (HP:0002185) | 1.95933081 |
| 109 | Distal upper limb amyotrophy (HP:0007149) | 1.95931440 |
| 110 | Upper limb amyotrophy (HP:0009129) | 1.95931440 |
| 111 | Abnormal platelet volume (HP:0011876) | 1.95271720 |
| 112 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.94762280 |
| 113 | Hypertriglyceridemia (HP:0002155) | 1.91612646 |
| 114 | Chest pain (HP:0100749) | 1.91087865 |
| 115 | Glomerulonephritis (HP:0000099) | 1.90733499 |
| 116 | Leukocytosis (HP:0001974) | 1.90160012 |
| 117 | Abnormality of carpal bone ossification (HP:0006257) | 1.89255753 |
| 118 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88967388 |
| 119 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88967388 |
| 120 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88967388 |
| 121 | Chronic sinusitis (HP:0011109) | 1.88697079 |
| 122 | Chronic diarrhea (HP:0002028) | 1.88279293 |
| 123 | Fragile skin (HP:0001030) | 1.87649282 |
| 124 | Increased cerebral lipofuscin (HP:0011813) | 1.86994041 |
| 125 | Prominent nose (HP:0000448) | 1.85520561 |
| 126 | Albinism (HP:0001022) | 1.85421978 |
| 127 | Autoimmune hemolytic anemia (HP:0001890) | 1.85399392 |
| 128 | Ependymoma (HP:0002888) | 1.84531180 |
| 129 | Thoracic kyphosis (HP:0002942) | 1.84506314 |
| 130 | Colon cancer (HP:0003003) | 1.83880039 |
| 131 | Premature rupture of membranes (HP:0001788) | 1.83580391 |
| 132 | Recurrent skin infections (HP:0001581) | 1.83522575 |
| 133 | Mediastinal lymphadenopathy (HP:0100721) | 1.83312901 |
| 134 | Xanthomatosis (HP:0000991) | 1.82840342 |
| 135 | Cholecystitis (HP:0001082) | 1.82178459 |
| 136 | Abnormal gallbladder physiology (HP:0012438) | 1.82178459 |
| 137 | Joint swelling (HP:0001386) | 1.81251814 |
| 138 | Pallor (HP:0000980) | 1.80474521 |
| 139 | Abnormality of the Achilles tendon (HP:0005109) | 1.79917167 |
| 140 | Aneurysm (HP:0002617) | 1.79907305 |
| 141 | Hematochezia (HP:0002573) | 1.79310187 |
| 142 | Increased connective tissue (HP:0009025) | 1.79190246 |
| 143 | Granulocytopenia (HP:0001913) | 1.78519643 |
| 144 | Abnormality of eosinophils (HP:0001879) | 1.78050792 |
| 145 | Cerebral inclusion bodies (HP:0100314) | 1.77948835 |
| 146 | Hypertensive crisis (HP:0100735) | 1.77918582 |
| 147 | Increased IgM level (HP:0003496) | 1.77594720 |
| 148 | Nuclear cataract (HP:0100018) | 1.77354590 |
| 149 | Radial bowing (HP:0002986) | 1.76691279 |
| 150 | Easy fatigability (HP:0003388) | 1.75873559 |
| 151 | Pulmonary embolism (HP:0002204) | 1.74851617 |
| 152 | Oral leukoplakia (HP:0002745) | 1.74766704 |
| 153 | Biconcave vertebral bodies (HP:0004586) | 1.73578804 |
| 154 | Obstructive sleep apnea (HP:0002870) | 1.73522336 |
| 155 | Cerebral aneurysm (HP:0004944) | 1.73485740 |
| 156 | Pulmonary infiltrates (HP:0002113) | 1.73264793 |
| 157 | Increased serum ferritin (HP:0003281) | 1.72106674 |
| 158 | Skin ulcer (HP:0200042) | 1.72041141 |
| 159 | Polycythemia (HP:0001901) | 1.71903497 |
| 160 | Prolonged neonatal jaundice (HP:0006579) | 1.71693614 |
| 161 | Acute lymphatic leukemia (HP:0006721) | 1.71652708 |
| 162 | Disproportionate tall stature (HP:0001519) | 1.71263899 |
| 163 | Microcytic anemia (HP:0001935) | 1.70840633 |
| 164 | Arterial thrombosis (HP:0004420) | 1.70807505 |
| 165 | Gingival bleeding (HP:0000225) | 1.70667907 |
| 166 | Recurrent sinusitis (HP:0011108) | 1.70516197 |
| 167 | Abnormal ossification of hand bones (HP:0005921) | 1.70485077 |
| 168 | Selective tooth agenesis (HP:0001592) | 1.70078320 |
| 169 | Myocardial infarction (HP:0001658) | 1.69995032 |
| 170 | Abnormality of reticulocytes (HP:0004312) | 1.69919629 |
| 171 | Hemoptysis (HP:0002105) | 1.68208880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.64124991 |
| 2 | EEF2K | 3.54787853 |
| 3 | TRIB3 | 3.38812543 |
| 4 | PKN2 | 3.13785444 |
| 5 | PRPF4B | 3.05252895 |
| 6 | MAP3K10 | 2.89980838 |
| 7 | ERN1 | 2.58253331 |
| 8 | IRAK3 | 2.49807665 |
| 9 | SMG1 | 2.27455128 |
| 10 | ZAP70 | 2.15799559 |
| 11 | MST1R | 2.15278136 |
| 12 | EPHA2 | 2.06841501 |
| 13 | TYK2 | 2.06276057 |
| 14 | SCYL2 | 2.05234099 |
| 15 | JAK3 | 2.04838557 |
| 16 | FLT3 | 1.90164538 |
| 17 | GRK6 | 1.87175480 |
| 18 | RIPK4 | 1.85797388 |
| 19 | BTK | 1.83989842 |
| 20 | LRRK2 | 1.82390640 |
| 21 | MAP3K3 | 1.79893169 |
| 22 | KDR | 1.78612118 |
| 23 | STK10 | 1.78514688 |
| 24 | FGFR4 | 1.75202203 |
| 25 | TESK2 | 1.66552122 |
| 26 | TBK1 | 1.62918411 |
| 27 | EPHB1 | 1.60656118 |
| 28 | KIT | 1.54691999 |
| 29 | TAOK2 | 1.50417542 |
| 30 | TXK | 1.50318355 |
| 31 | ITK | 1.50276363 |
| 32 | BLK | 1.48058815 |
| 33 | IKBKE | 1.41772486 |
| 34 | NME2 | 1.38564932 |
| 35 | TGFBR1 | 1.37706846 |
| 36 | LMTK2 | 1.33954782 |
| 37 | MAP3K11 | 1.31886056 |
| 38 | NEK2 | 1.30255507 |
| 39 | SYK | 1.29148377 |
| 40 | JAK1 | 1.28231160 |
| 41 | CDC42BPA | 1.25189901 |
| 42 | PRKD2 | 1.24708231 |
| 43 | SIK2 | 1.19279847 |
| 44 | RIPK1 | 1.19002120 |
| 45 | MAP2K3 | 1.18520902 |
| 46 | RPS6KA4 | 1.17234650 |
| 47 | CSF1R | 1.16574393 |
| 48 | MARK2 | 1.14985613 |
| 49 | PASK | 1.12179082 |
| 50 | PTK6 | 1.07361163 |
| 51 | MAP3K1 | 1.06353653 |
| 52 | TEC | 1.05044353 |
| 53 | CDK4 | 1.04838820 |
| 54 | CDC7 | 1.03342441 |
| 55 | HCK | 1.02908016 |
| 56 | RPS6KB2 | 1.01147553 |
| 57 | SIK1 | 0.98536687 |
| 58 | DDR2 | 0.98492978 |
| 59 | ARAF | 0.97885032 |
| 60 | LCK | 0.97513770 |
| 61 | TGFBR2 | 0.95736895 |
| 62 | EIF2AK1 | 0.94339591 |
| 63 | CSK | 0.93286393 |
| 64 | PDPK1 | 0.91927650 |
| 65 | TAOK1 | 0.90321777 |
| 66 | FGR | 0.89131000 |
| 67 | CDK12 | 0.87214409 |
| 68 | MAP3K8 | 0.84064565 |
| 69 | MAPKAPK3 | 0.83227232 |
| 70 | PAK4 | 0.82806202 |
| 71 | PTK2 | 0.81279192 |
| 72 | MAP3K7 | 0.81077561 |
| 73 | IRAK2 | 0.78571708 |
| 74 | BUB1 | 0.78556057 |
| 75 | PIM2 | 0.78128424 |
| 76 | TTN | 0.77383868 |
| 77 | MATK | 0.76756087 |
| 78 | PIM1 | 0.76345247 |
| 79 | JAK2 | 0.76294200 |
| 80 | ACVR1B | 0.75090955 |
| 81 | IRAK4 | 0.72627006 |
| 82 | FGFR3 | 0.72177493 |
| 83 | ATR | 0.71608427 |
| 84 | PRKD3 | 0.71354972 |
| 85 | CDK7 | 0.71237673 |
| 86 | BMX | 0.71056715 |
| 87 | FES | 0.71038124 |
| 88 | IKBKB | 0.68899514 |
| 89 | MAPK11 | 0.68812863 |
| 90 | ALK | 0.68620661 |
| 91 | MET | 0.68267562 |
| 92 | LYN | 0.67959426 |
| 93 | RPS6KA2 | 0.67773534 |
| 94 | MAP3K13 | 0.65956080 |
| 95 | BCKDK | 0.65480459 |
| 96 | ICK | 0.65024950 |
| 97 | MAP3K6 | 0.64667557 |
| 98 | KSR2 | 0.62447910 |
| 99 | TAOK3 | 0.61214941 |
| 100 | CLK1 | 0.60757438 |
| 101 | NLK | 0.60326581 |
| 102 | WEE1 | 0.59833263 |
| 103 | DYRK1B | 0.56261131 |
| 104 | RPS6KC1 | 0.55632757 |
| 105 | RPS6KL1 | 0.55632757 |
| 106 | TNK2 | 0.55309887 |
| 107 | TESK1 | 0.52497135 |
| 108 | CDK6 | 0.51238741 |
| 109 | HIPK2 | 0.50694684 |
| 110 | SIK3 | 0.50663973 |
| 111 | MAP2K6 | 0.50135893 |
| 112 | DAPK1 | 0.48844938 |
| 113 | PRKG2 | 0.48624287 |
| 114 | EIF2AK3 | 0.48167760 |
| 115 | ILK | 0.47002423 |
| 116 | MAPK12 | 0.45309433 |
| 117 | CHUK | 0.45161715 |
| 118 | PRKCH | 0.45035266 |
| 119 | TYRO3 | 0.43844397 |
| 120 | STK38 | 0.43731600 |
| 121 | MAP3K14 | 0.43381501 |
| 122 | STK4 | 0.43272752 |
| 123 | AURKB | 0.42731619 |
| 124 | CDK8 | 0.42551857 |
| 125 | MARK3 | 0.42233168 |
| 126 | MAPK7 | 0.41264322 |
| 127 | CAMKK1 | 0.41102255 |
| 128 | DYRK3 | 0.40120444 |
| 129 | NTRK1 | 0.37295269 |
| 130 | MTOR | 0.36937911 |
| 131 | RET | 0.36597101 |
| 132 | EPHB2 | 0.36161005 |
| 133 | RAF1 | 0.35970710 |
| 134 | NEK1 | 0.29809184 |
| 135 | TSSK6 | 0.29366105 |
| 136 | RPS6KA6 | 0.28368219 |
| 137 | PDGFRA | 0.27526574 |
| 138 | PDK1 | 0.27006271 |
| 139 | MAPKAPK2 | 0.26503026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.31557971 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.54319223 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.57094035 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.43751576 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.42452935 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.31541677 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.28791770 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.98242464 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97431354 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.93288331 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.93204419 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.89817619 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.73275844 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73267731 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70353727 |
| 16 | Spliceosome_Homo sapiens_hsa03040 | 1.69362267 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60561412 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53798395 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52890390 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.50888274 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46073007 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45794125 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44518822 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44107058 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43299082 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43188660 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40580860 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35658618 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.35545845 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.24544581 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23941624 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21482148 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19974040 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18735661 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.17967989 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17796025 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.17565475 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.17127940 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.12623219 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 1.10056310 |
| 41 | HTLV-I infection_Homo sapiens_hsa05166 | 1.08706595 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08681817 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.08230253 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.07658614 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.06692410 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06642640 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05890683 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01018576 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00897615 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00873050 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.00769557 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00760239 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98727242 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.96900756 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96302404 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96117176 |
| 57 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.95657315 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95254970 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.93925380 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93802788 |
| 61 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.92992342 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92674083 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92304025 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91997110 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91209441 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90484520 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.90361518 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90243274 |
| 69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.88987301 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88566328 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.87193045 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.86789309 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86133266 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86068748 |
| 75 | Allograft rejection_Homo sapiens_hsa05330 | 0.84959840 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84927221 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84447068 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.82469855 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.80629461 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.80302840 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80021838 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79817731 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78423378 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77877838 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76490860 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75345348 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75296332 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.74853117 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74244794 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72975007 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70267465 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.69713659 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69015413 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.67055554 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.66743746 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65932948 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65384922 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65249296 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64731324 |
| 100 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64368208 |
| 101 | RNA degradation_Homo sapiens_hsa03018 | 0.63730780 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63524106 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62533247 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61485317 |
| 105 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61433621 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60912281 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60740208 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60724806 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56466677 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56446025 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55873641 |
| 112 | Focal adhesion_Homo sapiens_hsa04510 | 0.55754405 |
| 113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54777050 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54491896 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53893022 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53703478 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.52948173 |
| 118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52134571 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51740076 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51393410 |
| 121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51172806 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51064478 |
| 123 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.50291122 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50064057 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49907335 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.49851418 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49597561 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.49447720 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47254418 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46823721 |
| 131 | Proteasome_Homo sapiens_hsa03050 | 0.43369891 |
| 132 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43251743 |
| 133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42634931 |
| 134 | ABC transporters_Homo sapiens_hsa02010 | 0.37980536 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37560823 |

